Výsledky vyhledávání - "Taylor Mandeville"

Abstract 1751: Prognostic value of CD20/CD73 ratio in sensitive and relapsed/refractory diffuse large B-cell lymphoma cell lines

Autor: Juan J. Gu, Cory Mavis, Jessica Wang, Taylor Mandeville, Francisco Hernandez-Ilizaliturri

Publikováno v: Cancer Research. 83:1751-1751

Purpose: Developing novel therapy strategies to treat relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) is critically needed. Previous studies in our group found despite dysregulation of apoptotic pathway in resistant DLBCL, upregulation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1315f1763ac1b7b7af102eefc97334a
https://doi.org/10.1158/1538-7445.am2023-1751

Zobrazit plný text záznamu

Enhancing α-CD19 CAR T Antitumor Efficacy Using the BH3 Mimetic, Venetoclax

Autor: Taylor Mandeville, Cory Mavis, Juan Gu, Noah Lemoine, Kevin Bowman, Scott Olejniczak, Prasenjit Dey, Gyorgy Paragh, Francisco Hernandez-Ilizaliturri

Publikováno v: Blood. 140:7398-7399

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05d9ccfb3c3314e3c0b670fd197c6e0f
https://doi.org/10.1182/blood-2022-170436

Zobrazit plný text záznamu

Abstract 2661: Novel pharmacological approaches of inhibiting the PI3K/AKT/mTOR signaling pathway in T-cell lymphoma (TCL)

Autor: Gabrielle Hartman, Cory Mavis, Juan J. Gu, Amber White, Taylor Mandeville, Pallawi Torka, Paola Ghione, Francisco J. Hernandez-Ilizaliturri

Publikováno v: Cancer Research. 82:2661-2661

Introduction: T-cell lymphoma (TCL) accounts for 15% of all non-Hodgkin’s lymphoma cases with most patients developing relapsed/refractory (R/R) disease. The management of R/R TCL is challenging and responses to second and beyond-line therapy are g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac92b75846df86e901e091935fc29dc7
https://doi.org/10.1158/1538-7445.am2022-2661

Zobrazit plný text záznamu

Novel metal-based photosensitizers for photodynamic therapy: exploratory study (Conference Presentation)

Autor: Lindsey Carlsen, Taylor Mandeville, Evan Bradner, Tariq Sainuddin, Sherri A. McFarland, Patrick C. Barrett, Gal Shafirstein, Sarah Chamberlain, David A. Bellnier

Publikováno v: 17th International Photodynamic Association World Congress.

Ruthenium and osmium-based photosensitizers (PS) are compounds of interest for use in photodynamic therapy (PDT). These PS’s can be activated by light wavelengths in the range of 400-675 nm, which can be selected based on the tumor environment, tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b04ca59dd027bc535a91b61d2059f19
https://doi.org/10.1117/12.2526180

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání